These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 18852578
1. Immediate and long-term results of treatment of complex lesions of the left anterior descending coronary artery involving a large diagonal branch with drug-eluting stents. Varbella F, Gagnor A, Tomassini F, Infantino V, Conte MR. J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1088-94. PubMed ID: 18852578 [Abstract] [Full Text] [Related]
11. The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. Grube E, Chevalier B, Smits P, Džavík V, Patel TM, Mullasari AS, Wöhrle J, Stuteville M, Dorange C, Kaul U, SPIRIT V Investigators. JACC Cardiovasc Interv; 2011 Feb 01; 4(2):168-75. PubMed ID: 21349455 [Abstract] [Full Text] [Related]
12. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease. De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F. Catheter Cardiovasc Interv; 2011 May 01; 77(6):765-72. PubMed ID: 21413124 [Abstract] [Full Text] [Related]
16. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience. Simard T, Hibbert B, Chong AY, Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O'Brien E. Catheter Cardiovasc Interv; 2012 Aug 01; 80(2):E15-22. PubMed ID: 21805580 [Abstract] [Full Text] [Related]